Colossal launches AI platform for de-extinction, backed by new fund

Colossal Biosciences has unveiled an AI platform to accelerate its de-extinction projects, and a new fund has been launched to back startups using the technology. The announcements were reported by TechCrunch.
The platform is designed to optimize genetic sequencing, species reconstruction, and lab workflows for Colossal’s efforts to revive extinct animals like the woolly mammoth. The new fund will target companies leveraging Colossal’s AI tools, though neither the fund’s size nor its first investments have been disclosed.
This development arrives as AI increasingly intersects with synthetic biology. Earlier coverage of hardware strategies for AI workloads highlighted enterprise endpoints; Colossal’s move suggests a parallel push toward AI-driven workflows in deep biology. The company has not released technical details about the platform, leaving open questions about its scalability and real-world impact.
The fund’s involvement adds validation, but its structure and thesis remain unclear. The de-extinction space has drawn both excitement and skepticism, with critics questioning the feasibility of reviving long-extinct species and the ethical implications of such projects. For now, the pairing of Colossal’s AI platform with a dedicated fund signals confidence in the commercial potential of AI-augmented biotech, even if the path to profitability is unproven.
Sources: techcrunch.com
“The move signals growing investor appetite for AI-driven biology startups, even as the field’s technical and ethical challenges remain unresolved.”
Read the original reporting
The outlets below did the original reporting.
Related briefs
- Intero Biosystems sells lab-grown human intestines to replace animal testing
- Oracle, DigitalOcean shares fall after CoreWeave debt worries spread
- SpaceXSI’s Grok Voice 3.0 tops speech-to-speech rankings
- CedarDB raises seed funding to bridge transactional and analytical databases
- Character.ai’s funding shift stirs AI sector caution
This brief was drafted automatically from the sources above and published under our editorial policy. Spotted an error? Tell us.